Cargando…

Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial

INTRODUCTION: Metformin has been demonstrated to enhance cardioprotective benefits in type 1 diabetes (T1DM). Although glycemic variability (GV) is associated with increased risk of CVD in diabetes, there is a scarcity of research evaluating the effect of metformin on GV in T1DM. OBJECTIVES: In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiuzhen, Xu, Dan, Xu, Ping, Yang, Shufen, Zhang, Qingmei, Wu, Yan, Yuan, Fengyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428086/ https://www.ncbi.nlm.nih.gov/pubmed/34343108 http://dx.doi.org/10.1530/EC-21-0146

Ejemplares similares

Significance of Glycemic Variability in Diabetes Mellitus
por: Kusunoki, Yoshiki, et al.
Publicado: (2021)

Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial
por: Iga, Ryo, et al.
Publicado: (2017)

Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-label Study
por: Gautam, Kumar, et al.
Publicado: (2023)

Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus
por: Cho, Young Min, et al.
Publicado: (2010)

Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis
por: Yu, Dan-Qing, et al.
Publicado: (2021)

Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study
por: Kim, Nam Hoon, et al.
Publicado: (2017)

Glycemic variability in normal glucose tolerance women with the previous gestational diabetes mellitus
por: Wang, Yong-mei, et al.
Publicado: (2015)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
por: Villar, Miriam Méndez-del, et al.
Publicado: (2017)

Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
por: Derosa, Giuseppe, et al.
Publicado: (2017)

How Can We Easily Measure Glycemic Variability in Diabetes Mellitus?
por: Chon, Suk
Publicado: (2015)

The Effect of Flaxseed Enriched Yogurt on the Glycemic Status and Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus: Randomized, Open-labeled, Controlled Study
por: Hasaniani, Nazila, et al.
Publicado: (2019)

Metformin May Contribute to Inter-individual Variability for Glycemic Responses to Exercise
por: Malin, Steven K., et al.
Publicado: (2020)

Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial
por: Ji, Linong, et al.
Publicado: (2013)

Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus
por: Nasykhova, Yulia A., et al.
Publicado: (2022)

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on metformin: a meta-analysis
por: Jingfan, Zhang, et al.
Publicado: (2019)

Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial
por: Li, Feng-fei, et al.
Publicado: (2016)

Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
por: Lee, Sharen, et al.
Publicado: (2021)

Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial
por: Raviteja, K. V., et al.
Publicado: (2019)

Abstract 129: Continuous glucose monitoring in type 2 diabetes mellitus to assess glycemic control and glycemic variability
Publicado: (2022)

Effect of metformin monotherapy and dual or triple concomitant therapy with metformin on glycemic control and lipid profile management of patients with type 2 diabetes mellitus
por: Lin, Yan-Yu, et al.
Publicado: (2022)

Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial
por: Lee, Seung-Eun, et al.
Publicado: (2019)

Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
por: Picconi, Fabiana, et al.
Publicado: (2017)

Efficacy and safety of add on therapy of bromocriptine with metformin in Indian patients with type 2 diabetes mellitus: A randomized open labeled phase IV clinical trial
por: Ghosh, Arijit, et al.
Publicado: (2014)

Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study
por: Kudo, Akihiro, et al.
Publicado: (2023)

Effect of combination therapy with repaglinide and metformin hydrochloride on glycemic control in Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2014)

Leptin and the rs2167270 Polymorphism Are Associated with Glycemic Control in Type Two Diabetes Mellitus Patients on Metformin Therapy
por: Alfaqih, Mahmoud A., et al.
Publicado: (2023)

Variability in the therapeutic response of Metformin treatment in patients with type 2 diabetes mellitus
por: Rashid, Maryam, et al.
Publicado: (2019)

Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
por: Zhang, Shuo, et al.
Publicado: (2023)

Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014)

Metformin in gestational diabetes mellitus
por: Tripathi, Reva, et al.
Publicado: (2017)

Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus
por: Nakata, Kei, et al.
Publicado: (2017)

Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus
por: Yokota, Shun, et al.
Publicado: (2019)

The Effects of Dietary Nutrition Intake on Glycemic Variability in Type 1 Diabetes Mellitus Adults
por: Zhou, Liyuan, et al.
Publicado: (2021)

Glycemic Variability in Type 1 Diabetes Mellitus Saudis Using Ambulatory Glucose Profile
por: Alzahrani, Bader, et al.
Publicado: (2021)

Exenatide once weekly combined with metformin reduced glycemic variability in type 2 diabetes by using flash glucose monitoring system
por: Li, Yang, et al.
Publicado: (2020)

Impact of Fixed Combination of Metformin and Pioglitazone on Insulin Resistance of Patients with Type 2 Diabetes: Results of a Randomized Open-Label Study
por: Sun, Rui, et al.
Publicado: (2023)

Development of a patient decision aid for type 2 diabetes mellitus for patients not achieving glycemic control on metformin alone
por: Shillington, Alicia C, et al.
Publicado: (2015)

Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus
por: Ahn, Ji Hoon, et al.
Publicado: (2016)

Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes
por: Pistrosch, F., et al.
Publicado: (2013)

Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial
por: Wang, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qb0j3vdla5d829u23p7jjiqvho